VREX
Varex Imaging Corporation NASDAQ Listed Jan 23, 2017$10.20
-2.86%
vs $10.50
Mkt Cap $422.3M
52w Low $6.96
43.8% of range
52w High $14.36
50d MA $10.88
200d MA $11.81
P/E (TTM)
-6.0x
EV/EBITDA
180.9x
P/B
0.9x
Debt/Equity
0.8x
ROE
-14.2%
P/FCF
22.5x
RSI (14)
54.20
ATR (14)
$0.52
Beta
1.00
50d MA
$10.88
200d MA
$11.81
Avg Volume
480.5K
Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys. This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.
1678 South Pioneer Road · Salt Lake City, UT 84104 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | AMC | 0.22 | 0.21 | -4.5% | 11.83 | -4.0% | -16.9% | -1.2% | +1.6% | +2.0% | -0.5% | — |
| Feb 10, 2026 | AMC | 0.14 | 0.19 | +35.7% | 14.15 | -10.3% | -3.8% | -1.7% | +1.0% | -0.1% | +2.1% | — |
| Nov 18, 2025 | AMC | 0.18 | 0.37 | +105.6% | 11.86 | -9.2% | -13.7% | +0.5% | +3.7% | +3.3% | +1.7% | — |
| Aug 7, 2025 | AMC | 0.04 | 0.18 | +350.0% | 7.81 | +10.0% | +21.4% | +3.1% | +8.2% | +1.1% | +0.8% | — |
| May 8, 2025 | AMC | 0.14 | 0.26 | +85.7% | 8.65 | -0.7% | -20.5% | +9.3% | -0.3% | -0.7% | +5.9% | — |
| Feb 6, 2025 | AMC | 0.04 | 0.07 | +75.0% | 15.20 | -11.2% | -19.3% | +5.6% | +4.2% | -0.4% | +1.3% | — |
| Nov 19, 2024 | AMC | 0.09 | 0.19 | +111.1% | 14.56 | +4.6% | +5.9% | +7.1% | +0.8% | -1.5% | +0.7% | — |
| Aug 1, 2024 | AMC | 0.19 | 0.14 | -26.3% | 14.27 | -8.4% | -9.0% | -5.1% | -5.4% | -1.7% | -0.5% | — |
| May 2, 2024 | AMC | 0.23 | 0.16 | -30.4% | 16.43 | -11.3% | -5.1% | +0.3% | +1.4% | -0.6% | +0.9% | — |
| Feb 6, 2024 | AMC | 0.11 | 0.06 | -45.5% | 19.44 | -6.1% | -9.2% | -3.1% | +3.2% | +0.7% | -4.4% | — |
| Nov 14, 2023 | AMC | 0.33 | 0.45 | +36.4% | 19.41 | -8.4% | -0.8% | -2.7% | +1.4% | +0.3% | +2.1% | — |
| Aug 1, 2023 | AMC | 0.33 | 0.37 | +12.1% | 23.01 | -1.2% | -2.6% | +1.1% | +0.2% | +0.1% | -1.8% | — |
| May 2, 2023 | AMC | 0.17 | 0.26 | +52.9% | 17.27 | +7.9% | +19.5% | +2.9% | +3.7% | +0.0% | -1.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19 | B. Riley Securities | Maintains | Buy → Buy | — | $11.86 | $10.77 | -9.2% | -13.7% | +0.5% | +3.7% | +3.3% | +1.7% |
| Nov 19 | Oppenheimer | Maintains | Outperform → Outperform | — | $11.86 | $10.77 | -9.2% | -13.7% | +0.5% | +3.7% | +3.3% | +1.7% |
| Aug 8 | B. Riley Securities | Maintains | Buy → Buy | — | $7.81 | $8.59 | +10.0% | +21.4% | +3.1% | +8.2% | +1.1% | +0.8% |
| Feb 7 | B. Riley Securities | Maintains | Buy → Buy | — | $15.20 | $13.50 | -11.2% | -19.3% | +5.6% | +4.2% | -0.4% | +1.3% |
| Feb 7 | Oppenheimer | Maintains | Outperform → Outperform | — | $15.20 | $13.50 | -11.2% | -19.3% | +5.6% | +4.2% | -0.4% | +1.3% |
| Nov 15 | Oppenheimer | Maintains | Outperform → Outperform | — | $19.41 | $17.77 | -8.4% | -0.8% | -2.7% | +1.4% | +0.3% | +2.1% |
| Aug 2 | Oppenheimer | Maintains | Outperform → Outperform | — | $23.01 | $22.74 | -1.2% | -2.6% | +1.1% | +0.2% | +0.1% | -1.8% |
| May 24 | Jefferies | Maintains | Hold → Hold | — | $21.69 | $21.84 | +0.7% | +0.6% | -1.1% | +0.8% | +0.6% | +0.7% |
| Oct 12 | Jefferies | Maintains | Hold → Hold | — | $21.08 | $20.85 | -1.1% | -9.3% | +4.4% | -0.2% | +2.6% | +0.3% |
| Feb 5 | Oppenheimer | Upgrade | Perform → Outperform | — | $19.89 | $25.00 | +25.7% | +17.9% | +0.4% | -2.7% | -2.4% | +4.0% |
| Aug 13 | Oppenheimer | Downgrade | Outperform → Perform | — | $16.00 | $13.10 | -18.1% | -19.8% | +5.2% | -4.8% | -4.0% | -2.3% |
| May 13 | Sidoti & Co. | Maintains | Buy → Buy | — | $25.32 | $20.50 | -19.0% | -32.6% | +9.1% | -5.9% | +6.8% | -4.9% |
| May 13 | JP Morgan | Downgrade | Overweight → Neutral | — | $25.32 | $20.50 | -19.0% | -32.6% | +9.1% | -5.9% | +6.8% | -4.9% |
| May 13 | Jefferies | Maintains | Hold → Hold | — | $25.32 | $20.50 | -19.0% | -32.6% | +9.1% | -5.9% | +6.8% | -4.9% |
| Mar 25 | JP Morgan | Upgrade | Neutral → Overweight | — | $19.49 | $20.66 | +6.0% | +2.6% | +5.8% | -5.4% | +4.9% | +8.3% |
| Feb 12 | Jefferies | Downgrade | Buy → Hold | — | $27.41 | $24.00 | -12.4% | -5.5% | +0.3% | -0.3% | -1.3% | +1.4% |
| Nov 13 | JP Morgan | Maintains | Neutral → Neutral | — | $32.67 | $33.00 | +1.0% | -9.9% | +1.2% | +1.2% | -2.8% | +0.6% |
| Oct 22 | Oppenheimer | Maintains | Outperform → Outperform | — | $29.14 | $29.50 | +1.2% | +0.1% | +1.5% | -3.1% | +1.4% | +2.1% |
| Mar 19 | Northland Securities | Maintains | Outperform → Outperform | — | $32.94 | $33.43 | +1.5% | +4.0% | -0.8% | +0.4% | -1.9% | -0.1% |
| Nov 14 | JP Morgan | Maintains | Neutral → Neutral | — | $26.11 | $24.99 | -4.3% | -6.0% | +2.0% | +5.0% | -2.5% | -5.3% |
| Dec 20 | JP Morgan | Upgrade | Underweight → Neutral | — | $37.84 | $38.00 | +0.4% | +4.9% | +2.1% | +1.3% | -0.7% | +1.0% |
| Oct 4 | JP Morgan | Downgrade | Neutral → Underweight | — | $34.59 | $32.70 | -5.5% | -3.6% | -0.9% | +0.4% | -0.5% | +0.2% |
| Aug 9 | Jefferies | Maintains | Buy → Buy | — | $29.20 | $29.39 | +0.7% | -1.0% | -0.8% | +1.5% | +3.3% | -2.5% |
| Aug 8 | JP Morgan | Upgrade | Underweight → Neutral | — | $28.27 | $28.96 | +2.4% | +3.3% | -1.0% | -0.8% | +1.5% | +3.3% |
| Apr 21 | JP Morgan | Downgrade | Neutral → Underweight | — | $36.04 | $34.74 | -3.6% | -2.6% | -1.3% | -1.9% | -0.5% | -0.4% |
No insider trades available.
8-K
Varex Imaging Corporation -- 8-K Filing
Varex Imaging reported Q2FY26 revenues of $216 million with solid demand across Medical and Industrial segments, though GAAP net loss of $0.19 per share was offset by non-GAAP earnings of $0.21 per share.
May 7
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
BMO and VREX secured significant credit facilities with subsidiary guarantees and standard covenants, potentially limiting financial flexibility but providing operational capital for growth or refinancing needs.
Mar 16
8-K
Varex Imaging Corporation -- 8-K Filing
I cannot provide a meaningful investment analysis from this filing summary, as it contains only technical metadata and schema references rather than substantive business information about Varex Imaging.
Feb 13
8-K
Varex Imaging Corporation -- 8-K Filing
Varex Imaging exceeded Q1FY26 guidance with $210 million revenue and $0.19 non-GAAP EPS, demonstrating solid operational performance despite $16 million negative operating cash flow.
Feb 10
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Pzena Investment Management Llc | 3,992,280 | $42M | — | Mar 2026 |
| 2 | Allspring Global Investments Holdings, Llc | 2,647,263 | $28M | — | Mar 2026 |
| 3 | Neuberger Berman Group Llc | 1,924,949 | $20M | Added | Mar 2026 |
| 4 | Vanguard Capital Management Llc | 1,820,336 | $19M | New | Mar 2026 |
| 5 | Frontier Capital Management Co Llc | 1,305,947 | $15M | Reduced | Dec 2025 |
| 6 | Cooke & Bieler Lp | 1,303,012 | $14M | Reduced | Mar 2026 |
| 7 | Rice Hall James & Associates, Llc | 1,082,964 | $13M | Added | Dec 2025 |
| 8 | Acadian Asset Management Llc | 1,140,499 | $12M | Added | Mar 2026 |
| 9 | D.e. Shaw & Co | 935,833 | $10M | Reduced | Mar 2026 |
| 10 | Vanguard Portfolio Management Llc | 920,607 | $10M | New | Mar 2026 |
| 11 | Morgan Stanley | 725,254 | $8M | Added | Dec 2025 |
| 12 | Aqr Capital Management Llc | 627,104 | $7M | Added | Mar 2026 |
| 13 | Two Sigma Investments, Lp | 581,072 | $6M | Added | Mar 2026 |
| 14 | Assenagon Asset Management S.a. | 461,887 | $5M | Reduced | Mar 2026 |
| 15 | Fmr Llc | 415,414 | $4M | Added | Mar 2026 |
| 16 | Connor, Clark & Lunn Investment Management Ltd. | 377,526 | $4M | — | Dec 2025 |
| 17 | Sei Investments Co | 411,655 | $4M | Added | Mar 2026 |
| 18 | Northern Trust Corp | 399,072 | $4M | Added | Mar 2026 |
| 19 | Qube Research & Technologies Ltd | 371,754 | $4M | Added | Mar 2026 |
| 20 | Bank Of America Corp /de/ | 337,699 | $4M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$422.3M
Enterprise Value
$633.2M
P/E (TTM)
-6.00x
Forward P/E
12.00x
PEG Ratio
-0.16x
P/B
0.87x
P/S
0.50x
P/FCF
22.46x
EV/EBITDA
180.91x
Shares Out
41.4M
Financials (TTM)
Revenue
$844.6M
Net Income
-$70.3M
EBITDA
$3.5M
Free Cash Flow
$18.8M
Op Cash Flow
$41.7M
EPS Basic
$-1.70
EPS Diluted
$-1.70
EPS Forward
$0.85
Gross Margin
34.4%
Op Margin
-3.3%
Net Margin
-8.3%
Balance Sheet
Total Assets
$1.11B
Total Liab.
$620.8M
Total Equity
$486.6M
Cash
$155.1M
LT Debt
$366.0M
Book Value/Sh
$11.75
Debt/Equity
0.85x
Current Ratio
3.43
Quick Ratio
1.83
Returns & Growth
ROE
-14.2%
ROA
-6.2%
ROIC
-3.0%
Rev Growth YoY
+4.1%
EPS Growth YoY
-45.3%
Price Returns
2W
+2.1%
1M
-12.2%
3M
-22.3%
6M
-11.6%
12M
+33.4%
Technicals
52W High
$14.36
52W Low
$6.96
50d MA
$10.88
200d MA
$11.81
RSI (14)
54.20
ATR (14)
$0.52
Beta
1.00
Avg Volume
481K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$14.50
High
$14.50
Low
$14.50
Median
$14.50
Data updated apr 27, 2026 8:06am
· Source: financialmodelingprep.com